title: Oroantral fistula from bisphosphonate induced osteonecrosis of the jaw.
abstract: Bisphosphonates like alendronic acid, disodium etidronate, and risedronate are effective for preventing postmenopausal and corticosteroid induced osteoporosis. They are also useful in the treatment of Paget's disease, hypercalcaemia of malignancy and in bony metastases. However osteonecrosis of the jaw has been reported following intravenous bisphosphonate use and rarely in those taking them orally. Increasingly, oroantral fistulae have been shown to occur as sequelae of bisphosphonate-induced osteonecrosis of the jaw and this case report highlights a patient that presented to our ENT department and required sinus surgery in collaboration with maxillofacial surgeons. This case report aims to raise awareness among ENT surgeons to these patients on bisphosphonates that could present to them with sinus disease from oroantral fistulae. There is an on-going audit in the maxillofacial community on this emerging trend.
authors.affiliation: William Harvey Hospital, Ashford, UK.
authors.forename: Olaleye
authors.initials: O
authors.lastname: Oladejo
authors.affiliation: William Harvey Hospital, Ashford, UK.
authors.forename: Bertram
authors.initials: B
authors.lastname: Fu
authors.affiliation: William Harvey Hospital, Ashford, UK.
authors.forename: Henry
authors.initials: H
authors.lastname: Sharp
authors.affiliation: William Harvey Hospital, Ashford, UK.
authors.forename: C
authors.initials: C
authors.lastname: Hendy